Bookmark
Forward
Explore Pharmaco Atlas Results
Explore Curated Studies Results
QuickView for hemi-methylated DNA-binding (biogroup)
Most Correlated Compounds
- Transforming Growth Factor beta2
- 5-((2,6-dichlorobenzyl)sulfonyl)-3-((3,5-dimethyl-4-((2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-1,3-dihydro-2H-indol-2-one
- Lasofoxifene
- N4-(2,2-dimethyl-3-oxo-4H-pyrid(1,4)oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine
- 2,4-Dinitrophenol
Most Correlated Studies
- Diffuse large B-cell lymphoma Karpas422 cells treated in a timecourse with EZH2 inhibitor EI1
- Response of breast tumors treated with docetaxel-capecitabine (+/- trastuzumab)
- Embryonic stem cells with dCas9-LSD1 epigenetically suppressed TBX3 or OCT4 expression
- Hormone responsiveness in breast cancer cell lines
- Prostate cancer cells with RB1 knockdown treated with dihydrotestosterone or GSK2879552
Most Relevant Literature
There were no matches for hemi-methylated DNA-binding
Explore Literature Results
Most Relevant Clinical Trials
There were no clinical trials for hemi-methylated DNA-binding
Explore Clinical Trials Results
